spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

UAE’s Falcon AI Powers Breakthrough Health Care Solution in US

 UAE-developed artificial intelligence technology is breaking new ground in American health care, with the open-source Falcon Large Language Model (LLM) being deployed to tackle language barriers for nearly 200,000 Arabic-speaking patients in Michigan. The initiative represents the first major US deployment of the UAE’s advanced AI capabilities in health care applications.

Velatura Public Benefit Corporation (Velatura), in partnership with J&B Medical, will unveil the initiative at the Caroline Kennedy Library in Dearborn on Sept. 18. The technology uses the UAE-developed open-source Falcon LLM to provide Arabic-English health care interactions for Dearborn’s Arabic speakers—the largest such population in the Western Hemisphere.

The deployment represents a significant milestone for UAE’s AI leadership globally, showcasing how Emirati-developed technology is addressing real-world health care challenges internationally. The initiative positions the UAE as a key player in global health AI innovation while preparing to bring the refined technology back to serve UAE citizens and residents across the Gulf region.
The company’s products, including the Arabic edition of Consent Manager+™ and the Velatura Intellibot™ operating system, represent a new category of multilingual Arabic-English AI products designed for health care applications. These solutions go beyond traditional translation, incorporating Reinforcement Learning with Human Feedback to deliver culturally authentic interactions for Arabic-speaking communities.

“This technology creates authentic Arabic-speaking user experiences that preserve cultural context and medical accuracy,” said Dr. Tim Pletcher, Chief Executive Officer of Velatura. “By fine-tuning Falcon’s capabilities through our custom-trained models, we’re building upon the leadership of the UAE as outlined in the UAE National Strategy for Artificial Intelligence 2031 and creating solutions that will benefit Arabic-speaking patients worldwide.”

J&B Medical, a market leader in health care focused on enhancing quality of life and improving clinical outcomes, brings extensive expertise in health care delivery and community engagement as co-host of the Sept. 18 launch event.

“This initiative demonstrates how innovation can transcend borders and cultures to create solutions that truly serve people,” said Stephen Shaya, M.D., Executive Servant Leader of J&B Medical. “By helping bring Falcon’s bilingual healthcare AI to life here in Michigan, we are not only advancing technology, we are advancing equity and compassion in care for communities across the world.”

While the UAE’s Falcon excels in multiple languages, particularly Arabic, it has seen limited real-world application internationally until now. Velatura’s approach bridges this gap, creating a model for global deployment of UAE AI technology that will ultimately benefit citizens and residents across the Emirates, Saudi Arabia, and Kuwait through enhanced VelaturaAI applications.

Prashant Natarajan, Chief Artificial Intelligence Officer of Velatura, explained the technology’s broader significance: “Our custom-trained models, fine-tuned from the Technology Innovation Institute’s UAE’s open-source Falcon LLM, create a new standard for bilingual health care AI. This deployment demonstrates how UAE innovation can address global challenges while establishing sustainable AI ecosystems that benefit both American and Emirati communities.”

Hot this week

Bayer CEO: overhaul is leading to pharma pipeline boost

Bayer Chief Executive Bill Anderson said the company is...

Roche shares rise as company advances experimental obesity drug to late-stage trial

Shares in Roche Holding rose around 2% on Monday,...

EXPERIMENTAL ANTIBIOTIC SHOWS PROMISE AGAINST SUPERBUGS

A synthetic antibiotic is showing potent activity against some...

New US Global Health Plan Prioritizes Drugs, Recipients’ Self-Reliance

The United States will prioritize frontline health supplies, staff,...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img